Standard BioTools Inc. (LAB)
NASDAQ$1.14
Market Cap
$432.04M
Sector
Healthcare
Industry
Medical—Diagnostics & Research
Rank in Sector
19 of 924
Rank in Industry
1 of 49
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
LAB Insider Trading Activity
LAB Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $22,977,164 | 23 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Casdin Partners Master Fund, L.P. | 23 | $22.98M | 0 | $0 | $22.98M |
About Standard BioTools Inc.
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical …
Insider Activity of Standard BioTools Inc.
Over the last 12 months, insiders at Standard BioTools Inc. have bought $22.98M and sold $0 worth of Standard BioTools Inc. stock.
On average, over the past 5 years, insiders at Standard BioTools Inc. have bought $13.45M and sold $514,009 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Casdin Partners Master Fund, L.P. () — $22.98M.
The last purchase of 4,820,959 shares for transaction amount of $5.13M was made by Casdin Partners Master Fund, L.P. () on 2025‑02‑28.
List of Insider Buy and Sell Transactions, Standard BioTools Inc.
| 2025-02-28 | Casdin Partners Master Fund, L.P. | 4.82M 1.2482% | $1.06 | $5.13M | +7.08% | |||
| 2024-08-27 | Casdin Partners Master Fund, L.P. | 250,000 0.0798% | $2.19 | $546,750 | -16.51% | |||
| 2024-08-26 | Casdin Partners Master Fund, L.P. | 150,000 0.0471% | $2.15 | $322,455 | -16.13% | |||
| 2024-08-23 | Casdin Partners Master Fund, L.P. | 292,100 0.0907% | $2.13 | $620,975 | -14.95% | |||
| 2024-08-22 | Casdin Partners Master Fund, L.P. | 307,900 0.088% | $1.96 | $602,807 | -6.67% | |||
| 2024-08-21 | Casdin Partners Master Fund, L.P. | 500,000 0.139% | $1.90 | $951,950 | -5.93% | |||
| 2024-08-20 | Casdin Partners Master Fund, L.P. | 500,000 0.1368% | $1.87 | $936,700 | -1.61% | |||
| 2024-08-19 | Casdin Partners Master Fund, L.P. | 250,000 0.0676% | $1.85 | $463,225 | -4.19% | |||
| 2024-08-14 | Casdin Partners Master Fund, L.P. | 1.2M 0.2794% | $1.59 | $1.91M | +18.06% | |||
| 2024-08-13 | Casdin Partners Master Fund, L.P. | 550,000 0.13% | $1.62 | $890,560 | +11.96% | |||
| 2024-08-12 | Casdin Partners Master Fund, L.P. | 500,000 0.1198% | $1.64 | $820,600 | +14.47% | |||
| 2024-08-09 | Casdin Partners Master Fund, L.P. | 525,408 0.1239% | $1.61 | $848,481 | +12.35% | |||
| 2024-08-08 | Casdin Partners Master Fund, L.P. | 569,562 0.1362% | $1.64 | $932,601 | +8.98% | |||
| 2024-08-07 | Casdin Partners Master Fund, L.P. | 500,000 0.1148% | $1.57 | $786,200 | +15.19% | |||
| 2024-08-05 | Casdin Partners Master Fund, L.P. | 200,000 0.0462% | $1.58 | $316,780 | +14.47% | |||
| 2024-08-02 | Casdin Partners Master Fund, L.P. | 1M 0.2382% | $1.63 | $1.63M | +10.30% | |||
| 2024-05-23 | Casdin Partners Master Fund, L.P. | 100,000 0.038% | $2.60 | $260,000 | -29.12% | |||
| 2024-05-22 | Casdin Partners Master Fund, L.P. | 150,000 0.0566% | $2.58 | $387,735 | -28.57% | |||
| 2024-05-21 | Casdin Partners Master Fund, L.P. | 350,000 0.1308% | $2.56 | $895,930 | -28.29% | |||
| 2024-05-20 | Casdin Partners Master Fund, L.P. | 100,000 0.0377% | $2.58 | $258,130 | -28.10% |
Total: 428
*Gray background shows transactions not older than one year
Insider Historical Profitability
15.57%
| Casdin Partners Master Fund, L.P. | 58846780 15.5274% | $67.09M | 28 | 0 | <0.0001% | |
| Caligan Partners LP | 10 percent owner | 11444836 3.0199% | $13.05M | 18 | 0 | <0.0001% |
| JOHNSON DAVID EDWARD | 11189663 2.9525% | $12.76M | 8 | 0 | <0.0001% | |
| LEVIN CAPITAL STRATEGIES, L.P. | 10 percent owner | 10473809 2.7636% | $11.94M | 111 | 0 | +23.89% |
| TORRAY ROBERT E | director | 2381164 0.6283% | $2.71M | 4 | 0 |
*Gray background shows insiders who have made transactions during last year
Historical Insider Profitability vs. Competitors
Standard BioTools Inc. (LAB) | $53,318,456 | 175 | 15.57% | $432.04M |
$38,597,637 | 114 | 658.88% | $2.47M | |
$1,590,764 | 16 | 3.90% | $55.22M | |
$26,663,659 | 7 | -12.13% | $20.04B | |
$151,252 | 6 | -58.10% | $11.58M |
LAB Institutional Investors: Active Positions
| Increased Positions | 63 | +39.38% | 14M | +4.93% |
| Decreased Positions | 61 | -38.13% | 17M | -5.94% |
| New Positions | 22 | New | 6M | New |
| Sold Out Positions | 21 | Sold Out | 1M | Sold Out |
| Total Postitions | 162 | +1.25% | 277M | -1.02% |
LAB Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Casdin Capital, Llc | $75,886.00 | 19.15% | 71.25M | 0 | 0% | 2024-12-31 |
| Viking Global Investors Lp | $62,463.00 | 15.77% | 58.65M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $26,474.00 | 6.68% | 24.86M | +2M | +10.71% | 2024-12-31 |
| Vanguard Group Inc | $18,271.00 | 4.61% | 17.16M | -135,946 | -0.79% | 2024-12-31 |
| Morgan Stanley | $17,946.00 | 4.53% | 16.85M | +2M | +10.53% | 2024-12-31 |
| Millennium Management Llc | $7,542.00 | 1.9% | 7.08M | +97,479 | +1.4% | 2024-12-31 |
| Geode Capital Management, Llc | $7,429.00 | 1.88% | 6.98M | +25,504 | +0.37% | 2024-12-31 |
| Sumitomo Mitsui Trust Group, Inc. | $7,049.00 | 1.78% | 6.62M | -3M | -30.9% | 2024-12-31 |
| Nikko Asset Management Americas, Inc. | $7,049.00 | 1.78% | 6.62M | -3M | -30.86% | 2024-12-31 |
| Tikvah Management Llc | $6,977.00 | 1.76% | 6.55M | 0 | 0% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.